Your Biological Age vs Your Real Age The Future of Heart Disease Prevention

Your Biological Age vs. Your Real Age_ The Future of Heart Disease Prevention. Three-panel infographic showing epigenetic clocks (GrimAge, DunedinPACE) integrated with cardiovascular biomarkers (ApoB, Lp(a), CAC) and RNA therapeutics for precision prevention of atherosclerotic cardiovascular disease. What are epigenetic clocks? DNA methylation-based biomarkers that measure biological aging — not calendar years. Three clocks matter for cardiology: 1️⃣ GrimAge → Mortality/CVD risk predictor 2️⃣ DunedinPACE → Pace of aging (how fast you're aging NOW) 3️⃣ PhenoAge → Clinical biomarker clock (no DNA test needed) GrimAge: The Mortality Predictor Trained on DNA methylation surrogates of 7 plasma proteins: PAI-1 (thrombosis) GDF-15 (cellular stress) Leptin (metabolism) TIMP-1 (matrix remodeling) 3 others + smoking Result: Predicts time-to-death better than any other biomarker. GrimAge + Cardiovascular Disease MESA study (n=2,969, 14-year follow-up): GrimAge acceleration predicted: 🔹 Composite CVD: HR 1.05 per year 🔹 MI: HR 1.06 🔹 Stroke: HR 1.07 🔹 Heart Failure: HR 1.08 Independent of: CAC, LDL-C, ApoB, BP, diabetes, smoking. 1️⃣ Chronological age is flawed 2️⃣ GrimAge predicts CV events independent of CAC 3️⃣ DunedinPACE monitors intervention response in 6-12 months 4️⃣ Combine with ApoB, Lp(a), hs-CRP, CAC 5️⃣ Lp(a) + accelerated aging = super high-risk 6️⃣ Not routine yet — but will be in 5-10 years . The Vision: ✅ Biological age measured at 30, 40, 50 — not just chronological age ✅ Accelerated aging → early, aggressive prevention ✅ DunedinPACE monitored q6-12mo to track intervention response ✅ Lp(a) RNA therapeutics for high-risk patients ✅ Healthspan — not just lifespan — becomes the outcome we optimize . This is the future of CV prevention. #TheLongevityHeart #Cardiology #PrecisionMedicine #Epigenetics #Longevity #Lipidology #PreventiveCardiology #BiologicalAging #GrimAge #DunedinPACE #Lp(a) #ApoB #PersonalizedMedicine #HealthTech #DigitalHealth #RNAtherapeutics #MetabolicHealth #Atherosclerosis #HeartDisease #StrokePrevention #HealthyAging #Medicine #Healthcare #Innovation #Research #ClinicalTrials #Biomarkers #RiskStratification @TeaGamezardashvili